Dose-response relation for atracurium, ORG NC 45 and pancuronium.

The potencies of atracurium, Org NC 45 and pancuronium were determined using cumulative dose-response curves. The effective doses producing 95% twitch depression were 279 microgram kg-1, 56 microgram kg-1 and 64 microgram kg-1 respectively, the relative potency being 1:5.0:4.3. The calculated log-probit dose-response curves showed the steepest slope for pancuronium, although the slopes did not deviate significantly from the parallel. The three drugs provided equal and generally good intubating conditions at approximately 95% twitch depression. Greater arterial pressure and heart rate were seen with pancuronium than with atracurium and Org NC 45.

[1]  N. Krieg,et al.  Intubation Conditions and Reversibility of a New Non-Depolarizing Neuromuscular Blocking Agent, Org-NC45 , 1981 .

[2]  R. Miller,et al.  Clinical Pharmacology of ORG NC45 (NorcuronTM): A New Nondepolarizing Muscle Relaxant , 1981, Anesthesiology.

[3]  N. Krieg,et al.  Influence of suxamethonium on the potency of ORG NC 45 in anaesthetized patients. , 1981, British Journal of Anaesthesia.

[4]  J. P. Payne,et al.  A Preliminary Assessment of Atracurium, a New Competitive Neuromuscular Blocking Agent , 1981, Acta Anaesthesiologica Scandinavica.

[5]  J. P. Payne,et al.  Evaluation of atracurium in anaesthetized man. , 1981, British journal of anaesthesia.

[6]  N. Krieg,et al.  Relative potency of ORG NC 45, pancuronium, alcuronium and tubocurarine in anaesthetized man. , 1981, British journal of anaesthesia.

[7]  H. H. Ali,et al.  Human dose-response curves for neuromuscular blocking drugs: a comparison of two methods of construction and analysis. , 1980, Anesthesiology.

[8]  D. Newton,et al.  The neuromuscular blocking action of ORG NC 45, a new pancuronium derivative, in anaesthetized patients. A pilot study. , 1980, British journal of anaesthesia.

[9]  P. H. Hansen,et al.  A new nerve stimulator (Myotest). , 1980, British journal of anaesthesia.

[10]  G. A. Harrison The cardiovascular effects and some relaxant properties of four relaxants in patients about to undergo cardiac surgery. , 1973, British Journal of Anaesthesia.

[11]  J. Downing,et al.  The immediate cardiovascular effects of pancuronium, alcuronium and tubocurarine in man , 1972, Anaesthesia.

[12]  R. Kitz,et al.  Neuromuscular blocking activity of a new series of quaternary N‐substituted choline esters , 1971, British journal of pharmacology.

[13]  G. R. Kelman,et al.  Cardiovascular effects of pancuronium in man. , 1971, British journal of anaesthesia.

[14]  I. Lund,et al.  DOSE‐RESPONSE CURVES FOR TUBOGURARINE, ALCURONIUM AND PANCURONIUM , 1970, Acta anaesthesiologica Scandinavica. Supplementum.